Literature DB >> 16489016

The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.

Il-Man Kim1, Timothy Ackerson, Sneha Ramakrishna, Maria Tretiakova, I-Ching Wang, Tanya V Kalin, Michael L Major, Galina A Gusarova, Helena M Yoder, Robert H Costa, Vladimir V Kalinichenko.   

Abstract

The proliferation-specific Forkhead Box m1 (Foxm1 or Foxm1b) transcription factor (previously called HFH-11B, Trident, Win, or MPP2) regulates expression of cell cycle genes essential for progression into DNA replication and mitosis. Expression of Foxm1 is found in a variety of distinct human cancers including hepatocellular carcinomas, intrahepatic cholangiocarcinomas, basal cell carcinomas, ductal breast carcinomas, and anaplastic astrocytomas and glioblastomas. In this study, we show that human Foxm1 protein is abundantly expressed in highly proliferative human non-small cell lung cancers (NSCLC) as well as in mouse lung tumors induced by urethane. To determine the role of Foxm1 during the development of mouse lung tumors, we used IFN-inducible Mx-Cre recombinase transgene to delete mouse Foxm1 fl/fl-targeted allele before inducing lung tumors with urethane. We show that Mx-Cre Foxm1-/- mice exhibit diminished proliferation of lung tumor cells causing a significant reduction in number and size of lung adenomas. Transient transfection experiments with A549 lung adenocarcinoma cells show that depletion of Foxm1 levels by short interfering RNA caused diminished DNA replication and mitosis and reduced anchorage-independent growth of cell colonies on soft agar. Foxm1-depleted A549 cells exhibit reduced expression of cell cycle-promoting cyclin A2 and cyclin B1 genes. These data show that Foxm1 stimulates the proliferation of tumor cells during progression of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489016     DOI: 10.1158/0008-5472.CAN-05-3003

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  169 in total

Review 1.  Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models.

Authors:  Tanya V Kalin; Vladimir Ustiyan; Vladimir V Kalinichenko
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

2.  Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.

Authors:  Vladimir Petrovic; Robert H Costa; Lester F Lau; Pradip Raychaudhuri; Angela L Tyner
Journal:  Cancer Biol Ther       Date:  2010-06-06       Impact factor: 4.742

3.  Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.

Authors:  Shahab Uddin; Azhar R Hussain; Maqbool Ahmed; Khawar Siddiqui; Fouad Al-Dayel; Prashant Bavi; Khawla S Al-Kuraya
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

4.  FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.

Authors:  Bingbing Dai; Russell O Pieper; Dawei Li; Ping Wei; Mingguang Liu; Shiao Y Woo; Kenneth D Aldape; Raymond Sawaya; Keping Xie; Suyun Huang
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

5.  FoxM1 involvement in astrocyte proliferation after spinal cord injury in rats.

Authors:  Shuangwei Zhang; Honglin Teng; Qiulei Ding; Jinpeng Fan; Wanying Shi; Yan Zhou; Chunwu Zhang
Journal:  J Mol Neurosci       Date:  2013-02-06       Impact factor: 3.444

6.  MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.

Authors:  Jian-Mei Wang; Bao-Hui Ju; Cai-Jun Pan; Yan Gu; Meng-Qi Li; Li Sun; Yan-Ying Xu; Li-Rong Yin
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

7.  Different expression of FoxM1 in human benign and malignant pleural effusion.

Authors:  Zhonghao Tang; Hongqing Li; Huili Zhu; Chunxue Bai
Journal:  Med Oncol       Date:  2014-12-10       Impact factor: 3.064

8.  Coexpression of FOXK1 and vimentin promotes EMT, migration, and invasion in gastric cancer cells.

Authors:  Hui Zhang; Xiaosheng Wu; Yizhi Xiao; Liqing Wu; Ying Peng; Weimei Tang; Guangnan Liu; Yong Sun; Jing Wang; Huiqiong Zhu; Mengwei Liu; Wenjing Zhang; Weiyu Dai; Ping Jiang; Aimin Li; Guoxin Li; Li Xiang; Side Liu; Jide Wang
Journal:  J Mol Med (Berl)       Date:  2018-11-27       Impact factor: 4.599

9.  Hedgehog signaling pathway: the must, the maybe and the unknown.

Authors:  Paul Zarogoulidis; Katerina Zarampouka; Haidong Huang; Kaid Darwiche; Yong Huang; Antonis Sakkas; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 10.  Basal cell carcinomas: attack of the hedgehog.

Authors:  Ervin H Epstein
Journal:  Nat Rev Cancer       Date:  2008-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.